Medical Oncology Prof. Dr. İbrahim Yıldız
✓ Medically verified profileProf. Dr. İbrahim Yıldız
✓ Medically verified profile
Quick answer
Prof. Dr. İbrahim Yıldız is a Medical Oncology specialist at Acibadem Atakent Hospital in İstanbul with 19+ years of experience.
He treats lung cancer and other thoracic malignancies, colorectal cancer including metastatic colorectal cancer and stage II colon cancer, esophageal cancer, triple-negative and HER2-positive breast cancer, and testicular germ cell tumors including seminoma, and provides treatments such as adjuvant chemotherapy, cisplatin plus fluorouracil chemotherapy, platinum-based chemotherapy, and tamoxifen therapy. He consults in…
About Prof. Dr. İbrahim Yıldız
Prof. Dr. İbrahim Yıldız is a Medical Oncology specialist with 19 years of experience. His listed areas of expertise include esophageal cancer, triple-negative breast cancer, testicular seminoma, stage II colon cancer, adjuvant chemotherapy, tamoxifen therapy, platinum-based chemotherapy, and cisplatin plus fluorouracil chemotherapy.
Dr. Yıldız graduated from Istanbul University Cerrahpasa Faculty of Medicine in 2003 and completed Internal Medicine at Istanbul University Cerrahpaşa Faculty of Medicine in 2006. He completed Medical Oncology at Istanbul University Istanbul Faculty of Medicine in 2013. He was at Kağıthane State Hospital from 2007 to 2009 and at War Academies Command for Military Service from 2009 to 2010. Dr. Yıldız joined Acibadem Health Group in 2015. He practises at Acibadem Atakent Hospital in İstanbul, Türkiye.
The profile lists four professional bodies, among them the European Society of Medical Oncology, the American Society of Clinical Oncology, and the Turkish Society of Medical Oncology.
The profile lists 10 publications dated between 2015 and 2015. Their subjects include testicular germ cell tumors, colorectal cancer and quality of life, and breast cancers with triple-negative and HER2-positive status.
Dr. Yıldız speaks Turkish and English. Online consultation is available, allowing patients abroad to speak with the doctor before travelling.
Areas of Expertise
Conditions treated and procedures performed by this specialist.
Education
- 2013Istanbul University Istanbul Faculty of Medicine Medical Oncology
- 2006Istanbul University Cerrahpaşa Faculty of Medicine Internal Medicine
- 2003Istanbul University Cerrahpasa Faculty of Medicine
Professional Experience
- 2015Acibadem Health Group
- 2013–2015Izmir Katip Çelebi University Atatürk Training and Research Hospital / Medical Oncology Clinic
- 2009–2010War Academies Command / Military Service
- 2007–2009Kağıthane State Hospital / Compulsory Service
Professional Memberships
- European Society of Medical Oncology
- Lung Cancer Association Board Member
- Turkish Society of Medical Oncology
- American Society of Clinical Oncology
Selected Publications
- Evaluation of c-kit (CD 117) expression as a prognostic factor in testicular germ cell tumors: An Izmir Oncology Group (IZOG) study. J BUON. 2015 Jul-Aug;20(4):1054-60 Salman T, Yildiz E, Yildiz I, Yavuzer D, Unlu M, Varol U, Akyol M, Yildiz Y, Bayoglu V, Kucukzeybek Y, Alacacioglu A
- Quality of life in colorectal cancer patients: an Izmir Oncology Group (IZOG) study. J BUON. 2015 Jul-Aug;20(4):1015-22. Akyol M, Ulger E, Alacacioglu A, Kucukzeybek Y, Bayoglu V, Yildiz Y, Yildiz I, Salman T, Varol U, Demir L, Dirican A, Gumus Z, Oktay Tarhan M.
- First-line cisplatin plus bolus 5- Fluorouracil combination in patients with locally advanced and metastatic esophageal cancer (Izmir Oncology Group study) Ahmet Alacacioglu, Mustafa Oktay Tarhan. Acta Oncol Tur. 2015; 48(1): 20-26 DOI: 10.5505/aot.2015.92408 Murat Akyol, Yüksel Küçükzeybek, Umut Varol, Ibrahim Yıldız, Suna Çokmert, İbrahim Vedat Bayoğlu, Yaşar Yıldız, Lutfiye Demir, Alper Can,Ahmet Dirican
- Prognostic value of mesothelin expression in patients with triple negative and HER2-positive breast cancers. Biomedicine & pharmacotherapy,2015 IV Bayoglu , BB Kucukzeybek , Y Kucukzeybek , U Varol , I Yildiz , A Alacacioglu , M Akyol , L Demir , A Dirican , Y Y Yildiz , T Salman , MO Tarhan.
- Adjuvant Chemotherapy and Prognostic Factors in Stage II Colon Cancer Varol Umut , Salman Tarik , Yildiz Ibrahim , Can Huseyin , Tarhan Mustafa Oktay Asian Pac J Cancer Prev vol 16, 2015, DOI:http://dx.doi.org/10.7314/APJ Kucukzeybek Yuksel , Dirican Ahmet , Demir Lutfiye , Yildirim Serkan , Akyol Murat , Yildiz Yasar , Bayoglu Ibrahim Vedat , Alacacioglu Ahmet ,
- D-dimer and international normalized ratio (INR) are correlated with tumor markers and disease stage in colorectal cancer patients. Cancer Biomark. 2015 Kilic L, Yildiz I, Sen FK, Erdem MG, Serilmez M, Keskin S, Ciftci R, Karabulut S, Ordu C, Duranyildiz D, Tas F.
- Sexual satisfaction, anxiety, depression and quality of life among Turkish colorectal cancer patients (Izmir Oncology Group (IZOG) study. Tarhan Mustafa Oktay.Japanese journal of clinical oncology,2015. Akyol Murat, Ulger Eda, Alacacioglu Ahmet, Kucukzeybek Yuksel, Yildiz Yasar, Gumus Zehra, Yildiz Ibrahim, Salman Tarik, Varol Umut, Ayakdas Semra,
- The Effect of Tamoxifen on Anxiety, Depression, Quality of Life and Sexual Satisfaction in a Premenopausal Breast Cancer Patient. İnci Alacacıoğlu , Mustafa Oktay Tarhan. Ahmet Alacacıoğlu, Eda Ülger, Umut Varol, İbrahim Yıldız, Tarık Salman, Vedat Bayoğlu, Ahmet Dirican, Murat Akyol, Yaşar Yıldız, Yüksel Küçükzeybek,
- Potential curative role of chemotherapy in patients with metastatic colorectal cancer with complete response to first-line chemotherapy. Acta Oncologica Turcica Varol Umut, Alacacioglu Ahmet, Yildiz Ibrahim, Tarhan Mustafa Oktay
- Multiple arterial occlusions precipitated by platinum based chemotherapy in a patient with testicular seminoma Journal-Cardiovascular Surgery, 1, Doi: 10.5455/jcvs.20131×12 Sen Fatma, Karavelioglu Yusuf, Yildiz Ibrahim, Sahin Dilek, Bavbek Sevil
Frequently Asked Questions
What is Dr. İbrahim Yıldız's specialty?
Which hospital does Dr. İbrahim Yıldız practise at?
What languages can I use when consulting Dr. İbrahim Yıldız?
How can I book an appointment with Dr. İbrahim Yıldız?
Is an online video consultation available with Dr. İbrahim Yıldız?
How many years of experience does Dr. İbrahim Yıldız have?
Can international patients arrange treatment with Dr. İbrahim Yıldız?
How do I get a second opinion involving Dr. İbrahim Yıldız?
A dedicated team, from first message to follow-up
Our international patient office coordinates your appointment, travel and treatment at JCI-accredited Acıbadem hospitals — and stays with you in your own language, every step of the way.
Schedule your appointment with Prof. Dr. İbrahim Yıldız
Choose a date and time that suits you. Our international patient team will check availability and confirm your appointment — usually within 24 hours.
- 1Choose your date & timePick a preferred day and time slot for your visit.
- 2Share your detailsTell us how to reach you and anything we should know.
- 3We confirm with youOur team confirms the appointment by phone or email.
Request your appointment
This request goes directly to this doctor’s schedule.
Your information stays strictly confidential and is used only to arrange your care.
Hospitals
Medical Units
Treatments Performed
What patients say about Prof. Dr. İbrahim Yıldız
★★★★★From 2,400+ verified patient reviews“Years of worry ended once I came here for my stroke rehabilitation. Dr. Yıldız was calm, precise and deeply reassuring. The facilities were spotless and modern.”
“I came to Acibadem for stroke rehabilitation and could not be happier with the outcome. Dr. Yıldız took the time to review my full history before recommending anything. I am deeply grateful for everything.”
“My son's physiotherapy went better than we ever hoped. Dr. Yıldızağı took real time to get our child's diagnosis right.”
“Choosing Acibadem for my dental implant treatment was the best decision I made. Dr. Yıldız went above and beyond what I expected. The facilities were spotless and modern.”